Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Neurorehabilitation Devices Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Neurorehabilitation Devices Industry
  • 1.7 COVID-19 Impact: Neurorehabilitation Devices Market Trends

    • 2 Global Neurorehabilitation Devices Quarterly Market Size Analysis

    • 2.1 Neurorehabilitation Devices Business Impact Assessment - COVID-19
      • 2.1.1 Global Neurorehabilitation Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Neurorehabilitation Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Neurorehabilitation Devices Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Neurorehabilitation Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Neurorehabilitation Devices Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Neurorehabilitation Devices Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Neurorehabilitation Devices Market
    • 3.5 Key Manufacturers Neurorehabilitation Devices Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Neurorehabilitation Devices Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Neurorobotic System
      • 1.4.2 Brain Computer Interface
      • 1.4.3 Non-invasive Stimulators
      • 1.4.4 Wearable Devices
      • 1.4.5 Other
    • 4.2 By Type, Global Neurorehabilitation Devices Market Size, 2019-2021
      • 4.2.1 By Type, Global Neurorehabilitation Devices Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Neurorehabilitation Devices Price, 2020-2021

    5 Impact of Covid-19 on Neurorehabilitation Devices Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Other
    • 5.2 By Application, Global Neurorehabilitation Devices Market Size, 2019-2021
      • 5.2.1 By Application, Global Neurorehabilitation Devices Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Neurorehabilitation Devices Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Medtronic PLC
      • 7.1.1 Medtronic PLC Business Overview
      • 7.1.2 Medtronic PLC Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.1.3 Medtronic PLC Neurorehabilitation Devices Product Introduction
      • 7.1.4 Medtronic PLC Response to COVID-19 and Related Developments
    • 7.2 Abbott
      • 7.2.1 Abbott Business Overview
      • 7.2.2 Abbott Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.2.3 Abbott Neurorehabilitation Devices Product Introduction
      • 7.2.4 Abbott Response to COVID-19 and Related Developments
    • 7.3 Agiliad
      • 7.3.1 Agiliad Business Overview
      • 7.3.2 Agiliad Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.3.3 Agiliad Neurorehabilitation Devices Product Introduction
      • 7.3.4 Agiliad Response to COVID-19 and Related Developments
    • 7.4 AlterG
      • 7.4.1 AlterG Business Overview
      • 7.4.2 AlterG Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.4.3 AlterG Neurorehabilitation Devices Product Introduction
      • 7.4.4 AlterG Response to COVID-19 and Related Developments
    • 7.5 Bioness
      • 7.5.1 Bioness Business Overview
      • 7.5.2 Bioness Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.5.3 Bioness Neurorehabilitation Devices Product Introduction
      • 7.5.4 Bioness Response to COVID-19 and Related Developments
    • 7.6 Hocoma AG
      • 7.6.1 Hocoma AG Business Overview
      • 7.6.2 Hocoma AG Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.6.3 Hocoma AG Neurorehabilitation Devices Product Introduction
      • 7.6.4 Hocoma AG Response to COVID-19 and Related Developments
    • 7.7 Ekso Bionics Holding
      • 7.7.1 Ekso Bionics Holding Business Overview
      • 7.7.2 Ekso Bionics Holding Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.7.3 Ekso Bionics Holding Neurorehabilitation Devices Product Introduction
      • 7.7.4 Ekso Bionics Holding Response to COVID-19 and Related Developments
    • 7.8 Bioxtreme Robotics Rehabilitation
      • 7.8.1 Bioxtreme Robotics Rehabilitation Business Overview
      • 7.8.2 Bioxtreme Robotics Rehabilitation Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.8.3 Bioxtreme Robotics Rehabilitation Neurorehabilitation Devices Product Introduction
      • 7.8.4 Bioxtreme Robotics Rehabilitation Response to COVID-19 and Related Developments
    • 7.9 Denecor
      • 7.9.1 Denecor Business Overview
      • 7.9.2 Denecor Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.9.3 Denecor Neurorehabilitation Devices Product Introduction
      • 7.9.4 Denecor Response to COVID-19 and Related Developments
    • 7.10 Ectron
      • 7.10.1 Ectron Business Overview
      • 7.10.2 Ectron Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.10.3 Ectron Neurorehabilitation Devices Product Introduction
      • 7.10.4 Ectron Response to COVID-19 and Related Developments
    • 7.11 Helius
      • 7.11.1 Helius Business Overview
      • 7.11.2 Helius Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.11.3 Helius Neurorehabilitation Devices Product Introduction
      • 7.11.4 Helius Response to COVID-19 and Related Developments
    • 7.12 Interactive Motion Technologies
      • 7.12.1 Interactive Motion Technologies Business Overview
      • 7.12.2 Interactive Motion Technologies Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.12.3 Interactive Motion Technologies Neurorehabilitation Devices Product Introduction
      • 7.12.4 Interactive Motion Technologies Response to COVID-19 and Related Developments
    • 7.13 Kinestica
      • 7.13.1 Kinestica Business Overview
      • 7.13.2 Kinestica Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.13.3 Kinestica Neurorehabilitation Devices Product Introduction
      • 7.13.4 Kinestica Response to COVID-19 and Related Developments
    • 7.14 Kinetic Muscles
      • 7.14.1 Kinetic Muscles Business Overview
      • 7.14.2 Kinetic Muscles Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.14.3 Kinetic Muscles Neurorehabilitation Devices Product Introduction
      • 7.14.4 Kinetic Muscles Response to COVID-19 and Related Developments
    • 7.15 Neurostyle
      • 7.15.1 Neurostyle Business Overview
      • 7.15.2 Neurostyle Neurorehabilitation Devices Quarterly Production and Revenue, 2020
      • 7.15.3 Neurostyle Neurorehabilitation Devices Product Introduction
      • 7.15.4 Neurostyle Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Neurorehabilitation Devices Supply Chain Analysis
      • 8.1.1 Neurorehabilitation Devices Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Neurorehabilitation Devices Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Neurorehabilitation Devices Distribution Channels
      • 8.2.2 Covid-19 Impact on Neurorehabilitation Devices Distribution Channels
      • 8.2.3 Neurorehabilitation Devices Distributors
    • 8.3 Neurorehabilitation Devices Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Neurorehabilitation Devices, including the following market information:
      Global Neurorehabilitation Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Neurorehabilitation Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Neurorehabilitation Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Neurorehabilitation Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Medtronic PLC, Abbott, Agiliad, AlterG, Bioness, Hocoma AG, Ekso Bionics Holding, Bioxtreme Robotics Rehabilitation, Denecor, Ectron, Helius, Interactive Motion Technologies, Kinestica, Kinetic Muscles, Neurostyle, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Neurorobotic System
      Brain Computer Interface
      Non-invasive Stimulators
      Wearable Devices
      Other

      Based on the Application:
      Hospitals
      Clinics
      Other

      Buy now